StockData
OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

ORASURE TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.68+0.07 (+1.94%)

Close on Oct 19, 2026

Market cap
$258.18M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 4, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 5, 2026After market close$30.60M$0.09$-0.20
Q1 FY2026
Ended Mar 31, 2026
May 6, 2026After market close$27.90M––
Q4 FY2025
Ended Dec 31, 2025
Feb 25, 2026After market close$26.80M$-0.27$-0.19
Q3 FY2025
Ended Sep 30, 2025
Nov 5, 2025After market close$27.10M$-0.19$-0.13
Q2 FY2025
Ended Jun 30, 2025
Aug 5, 2025After market close$31.20M––
Q1 FY2025
Ended Mar 31, 2025
May 7, 2025After market close$29.90M$-0.21$-0.18
Q4 FY2024
Ended Dec 31, 2024
Feb 25, 2025After market close$37.40M$-0.14$-0.06
Q3 FY2024
Ended Sep 30, 2024
Nov 6, 2024After market close$39.90M$-0.06$-0.01
Q2 FY2024
Ended Jun 30, 2024
Aug 6, 2024After market close$54.30M$-0.01$0.07
Q1 FY2024
Ended Mar 31, 2024
May 8, 2024After market close$54.10M$-0.05$0.04
Q4 FY2023
Ended Dec 31, 2023
Feb 27, 2024After market close$75.90M$0.27$0.22

Company guidance

Outlook given with results on Aug 5, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
total revenuesQ3 2026$29.50M to $32.50MNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Orasure Technologies filed with the SEC